On Capitol Hill, PBM Execs Deny Role In High Drug Costs
By Mark Payne · July 23, 2024, 4:22 PM EDT
Executives from the nation's three largest pharmacy benefit managers told members of a U.S. House committee on Tuesday that they lower drug costs while pointing the finger at pharmaceutical manufacturers....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login